Cargando…

In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, is a novel strain of coronavirus first reported in December 2019 which rapidly spread throughout the world and was subsequently declared a pandemic by the World Health Organization (WHO) in March 2020....

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Adrian Josiah T., Macalino, Stephani Joy Y., Billones, Junie B., Balolong, Marilen Parungao, Murao, Lyre Anni E., Carrillo, Maria Constancia O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540280/ https://www.ncbi.nlm.nih.gov/pubmed/36205801 http://dx.doi.org/10.1007/s00894-022-05334-1

Ejemplares similares

In Silico Strategies in Tuberculosis Drug Discovery
por: Macalino, Stephani Joy Y., et al.
Publicado: (2020)

Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosis l,d-transpeptidase 2
por: Billones, Junie B, et al.
Publicado: (2016)

In silico discovery and in vitro activity of inhibitors against Mycobacterium tuberculosis 7,8-diaminopelargonic acid synthase (Mtb BioA)
por: Billones, Junie B, et al.
Publicado: (2017)

Strengthening health systems resilience using environmental surveillance for COVID-19 and antimicrobial resistance in the Philippines
por: Salazar, Miguel Antonio, et al.
Publicado: (2022)

Emerging Genomic Trends on Rabies Virus in Davao Region, Philippines, 2018–2021
por: Capin, Jessel Babe G., et al.
Publicado: (2023)

Dengue and Soluble Mediators of the Innate Immune System
por: Espada-Murao, Lyre Anni, et al.
Publicado: (2011)

A cointegration analysis of rabies cases and weather components in Davao City, Philippines from 2006 to 2017
por: Lachica, Zython Paul T., et al.
Publicado: (2020)

The first complete mitochondrial genome sequence of Cynopterusbrachyotis (Chiroptera, Pteropodidae) from the Philippines
por: Gaite, Paul Lorenzo A., et al.
Publicado: (2022)

In Ovo and In Silico Evaluation of the Anti-Angiogenic Potential of Syringin
por: Aventurado, Charlaine A, et al.
Publicado: (2020)

Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery
por: Macalino, Stephani Joy Y., et al.
Publicado: (2018)

An in-silico investigation of potential natural polyphenols for the targeting of COVID main protease inhibitor
por: Aljarba, Nada H., et al.
Publicado: (2022)

In-silico screening of naturally derived phytochemicals against SARS-CoV Main protease
por: Mostafa, Islam, et al.
Publicado: (2021)

Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences
por: Narkhede, Rohan R., et al.
Publicado: (2020)

Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease
por: Elkaeed, Eslam B., et al.
Publicado: (2022)

In silico approach for identification of natural compounds as potential COVID 19 main protease (M(pro)) inhibitors
por: Chaturvedi, Monika, et al.
Publicado: (2021)

In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants
por: Umar, Haruna I., et al.
Publicado: (2021)

Synthesis and crystal structure of [2,7,12-trimethyl-3,7,11,17-tetraazabicyclo[11.3.1]heptadeca-1(17),13,15-triene-κ(4) N]copper(II) bis(perchlorate)
por: Hilvano, Edward Gabrielle V., et al.
Publicado: (2016)

In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library
por: Shahhamzehei, Nasim, et al.
Publicado: (2022)

A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease
por: Elkaeed, Eslam B., et al.
Publicado: (2022)

An in-silico evaluation of COVID-19 main protease with clinically approved drugs
por: Tachoua, Wafa, et al.
Publicado: (2020)

Statins and the COVID-19 main protease: in silico evidence on direct interaction
por: Reiner, Željko, et al.
Publicado: (2020)

In silico screening, SAR and kinetic studies of naturally occurring flavonoids against SARS CoV-2 main protease
por: Imran, Muhammad, et al.
Publicado: (2022)

Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2: In silico study
por: Kumar, Nitish, et al.
Publicado: (2021)

In silico identification of natural products from Centella asiatica as severe acute respiratory syndromecoronavirus 2 main protease inhibitor
por: Maya, Putu Gita, et al.
Publicado: (2021)

In silico identification of natural compounds against SARS-CoV-2 main protease from Chinese herbal medicines
por: Kuang, Yi, et al.
Publicado: (2023)

In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease
por: Abdelrady, Yousef A, et al.
Publicado: (2023)

Association of Mast Cell-Derived VEGF and Proteases in Dengue Shock Syndrome
por: Furuta, Takahisa, et al.
Publicado: (2012)

Acridone Alkaloids: In-Silico Investigation Against SARS-CoV-2 Main Protease
por: Oderinlo, Ogunyemi Olajide, et al.
Publicado: (2022)

In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus
por: Eleftheriou, Phaedra, et al.
Publicado: (2020)

Erratum: In silico identification of natural products from Centella asiatica as severe acute respiratory syndrome-coronavirus 2 main protease inhibitor
Publicado: (2021)

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
por: Teli, Divya M., et al.
Publicado: (2021)

Exploring the Binding Effects of Natural Products and Antihypertensive Drugs on SARS-CoV-2: An In Silico Investigation of Main Protease and Spike Protein
por: Moschovou, Kalliopi, et al.
Publicado: (2023)

Multifaceted Assessment of Wastewater-Based Epidemiology for SARS-CoV-2 in Selected Urban Communities in Davao City, Philippines: A Pilot Study
por: Otero, Maria Catherine B., et al.
Publicado: (2022)

Hordatines as a Potential Inhibitor of COVID-19 Main Protease and RNA Polymerase: An In-Silico Approach
por: Dahab, Mohammed A., et al.
Publicado: (2020)

In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds
por: Babaeekhou, Laleh, et al.
Publicado: (2021)

2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies
por: Hariyono, Pandu, et al.
Publicado: (2022)

Apigenin analogues as SARS-CoV-2 main protease inhibitors: In-silico screening approach
por: Farhat, Ameny, et al.
Publicado: (2022)

In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor
por: Wen, Lei, et al.
Publicado: (2021)

Screening, molecular simulation & in silico kinetics of virtually designed covid-19 main protease inhibitors
por: Aleissa, Mohammed S., et al.
Publicado: (2022)

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
por: Gao, Menghan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aujbrout8i10vrhncibuuh3gsd